We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01540643
First Posted: February 29, 2012
Last Update Posted: January 20, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Cook Group Incorporated
February 23, 2012
February 29, 2012
January 20, 2017
March 2012
March 2016   (Final data collection date for primary outcome measure)
Assess short term and longer term outcomes, including outcomes related to patency, of the Zenith® Spiral-Z® AAA Iliac Leg Graft. [ Time Frame: 12 months ]
Same as current
Complete list of historical versions of study NCT01540643 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients implanted with an FDA approved Zenith® Spiral-Z® AAA Iliac Leg Graft
  • Abdominal Aortic Aneurysm
  • Aorto-iliac Aneurysm
Device: Iliac Leg Graft
Zenith® Spiral-Z® AAA Iliac Leg Graft
Abdominal aortic aneurysm
Intervention: Device: Iliac Leg Graft
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
600
March 2016
March 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient is implanted with Zenith® Spiral-Z® AAA Iliac Leg Graft.

Exclusion Criteria:

  • Patients for whom this device would not normally be considered standard of care.
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Canada,   United States
 
 
NCT01540643
11-015
Not Provided
Not Provided
Not Provided
Cook Group Incorporated
Cook Group Incorporated
Not Provided
Principal Investigator: Thomas Lindsay Toronto General Hospital
Cook Group Incorporated
January 2017